BIOVECTRA is proud to be selected as one of Canada’s Top 100 Employers for 2022 and considered amongst some of the country’s leading workplaces.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211112005361/en/

As one of four Atlantic Canadian companies selected, BIOVECTRA is a fast growing, forward-thinking, global pharmaceutical contract development and manufacturing organization (CDMO) solving complex challenges to meet patient needs. From modest beginnings as a Startup company designed to give local science talent opportunities, BIOVECTRA has grown into a diverse workplace of more than 550 employees with state-of-the-art manufacturing facilities in Prince Edward Island and Nova Scotia.

People and the growth of talent is hard-coded into BIOVECTRA’s DNA.

Manufacturing Manager Adam MacDonald started with BIOVECTRA as a chemical processing operator right out of high school and now is responsible for 32 employees and ensuring that high-quality product gets delivered to clients. “Mentoring by good people and being supported to take on new roles and responsibilities has led to a full career at BIOVECTRA for me,” says Mr. MacDonald.

“We are thrilled to take our place among Canada’s Top 100 Employers. This means a great deal to us because BIOVECTRA firmly believes in the idea that valuing our people and creating the conditions for their growth goes hand-in-hand with our success,” explains CEO Oliver Technow. “People’s contributions are not only welcome, they are essential, because at BIOVECTRA we think of ourselves as relentless problem solvers that also deeply care and respect each other.”

A few of the reasons BIOVECTRA was selected as one of Canada’s Top 100 Employers include a longstanding practice to develop employees through new opportunities and formal education. It has established a People’s Council to help actively shape workplace culture and has recently expanded health and maternity benefits.

Growth did not stop for BIOVECTRA, even with the challenges brought on by the global pandemic; it onboarded over 200 new employees in 18 months.

“As BIOVECTRA continues to grow, becomes more diverse, and competes in the global market our leadership team is more committed than ever to making employees feel valued, supported, and encouraged to give their best,” reflects Mr. Technow.

Helpful Links

www.biovectra.com

https://www.canadastop100.com/national/

About BIOVECTRA

BIOVECTRA is a global biotech and pharmaceutical CDMO (contract development and manufacturing organization) that specializes in clinical-to-commercial scale production capabilities for: biologics, bioreagents, fermented small molecules, synthetic small molecules, and active pharmaceutical ingredients. Flexibility, creativity, process optimization and compliance are at the heart of our method. With over 550 employees and cGMP facilities in Prince Edward Island and Nova Scotia, Canada we assure our programs advance on time and with the highest quality outcomes.

About the 2022 Competition

Now in its 22nd edition, Canada’s Top 100 Employers is an editorial competition that recognizes employers with exceptional human resources programs and forward-thinking workplace policies. Editors at Mediacorp review employers on eight criteria, which have remained consistent since the project’s inception: (1) Physical Workplace; (2) Work Atmosphere & Social; (3) Health, Financial &Family Benefits; (4) Vacation & Time Off; (5) Employee Communications; (6) Performance Management; (7) Training & Skills Development; and (8) Community Involvement. The editors publish detailed ‘reasons for selection’ for these criteria, providing transparency in the selection of winners and a catalogue of best practices for employers and job-seekers alike.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211112005361/en/